KORELASI ANTARA HITUNG TROMBOSIT DENGAN JUMLAH CD4 PASIEN HIV/AIDS

Abstract

The Acquired Immune Deficiency Syndrome (AIDS) is the presence of symptoms caused by Human Immunodeficiency Virus (HIV)
which belongs to human retroviruses (retroviridae). Thrombocytopenia is a common finding in patients with HIV infection. HIV infection
may induce thrombocytopenia through immune and non-immune mechanisms, autoimmune combination and inhibition of platelet
production. The aim of this study is to analyze the correlation between thrombocyte and CD4 count in HIV/AIDS patients. This study
uses a cross sectional design with a total of 17 patients. The subject of this study is HIV/AIDS patients who came to and examined at
VCT clinic, dr. Moewardi Hospital Surakarta. To analyze this result the researchers used Spearman (r) correlation with p<0.05, and
confidence interval 95%. Patients' median age was 30 (21–49) years, 11 (64.7%) men and 6 (35.3%) women. The subjects with AIDS
were 11 (64.7%), and HIV were 6 (35.3%) patients. The duration of antiretroviral (ARV) was 7.5 (4–20) months in 10 subjects.
The median of thrombocyte count was 203 (143–327)í—103/μL, CD4 absolute 207 (5.0–734)/μL, and CD4 (% lymphocytes) 13.0
(2.0–29.0)%. The thrombocyte count was not correlated with CD4 absolute (r=0.456; p=0.066) and CD4% (r=0.218; p=0.400). In
HIV patients, low platelet counts will be the result of a host of problems and complications that are associated with the progressive HIV
infection or its management.